Lancartama Sejati Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Lancartama Sejati Tbk. trades at Rp262 (market cap 302.4B, 32.74M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 41.6× Lancartama Sejati Tbk.'s market cap, and Lancartama Sejati Tbk. is more actively traded (32.74M versus 235.2K). Which is the better fit depends on your goals.
| TAMA | TSPC | |
|---|---|---|
Market Cap | 302.4B | 12.58T |
Volume | 32.74M | 235.2K |
Lot | 327.41K | 2.35K |
Turnover | 8.76B | 649.94M |
Average Price | 267.41 | 2,763.37 |
Value | 8.76B | 649.94M |
Indicative Equilibrium Price | 262 | 2,780 |
Indicative Equilibrium Volume | 9.25K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lancartama Sejati Tbk (the Company) was established based on notary deed No. 12 dated June 01, 1990 of Sugiri Kadarisman, SH., notary in Jakarta.
Read more on TAMA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →